Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma

por BO, QI-FU, SUN, XIU-MEI, LIU, JIN, SUI, XIAO-MEI, LI, GUI-XIN
Publicado 2015

The different radiosensitivity when combining erlotinib with radiation at different administration schedules might be related to activity variations in c-MET-PI3K-AKT signal transd...

por Zhuang, Hong-Qing, Bo, Qi-Fu, Yuan, Zhi-Yong, Wang, Jun, Zhao, Lu-Jun, Wang, Ping
Publicado 2013